Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles.
about
Biodegradable, polymer encapsulated, metal oxide particles for MRI-based cell trackingSynthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.PEG-functionalized magnetic nanoparticles for drug delivery and magnetic resonance imaging applications.Polymeric nanoparticles for targeted radiosensitization of prostate cancer cellsMagnetic nanoparticle drug carriers and their study by quadrupole magnetic field-flow fractionation.Paracoccidioidomycosis: eco-epidemiology, taxonomy and clinical and therapeutic issues.A Functional Iron Oxide Nanoparticles Modified with PLA-PEG-DG as Tumor-Targeted MRI Contrast Agent.Detection of PLGA-based nanoparticles at a single-cell level by synchrotron radiation FTIR spectromicroscopy and correlation with X-ray fluorescence microscopy.Anticancer studies of drug encapsulated polyethylene terephthalate-Co-polylactic acid nanocapsules.Gold and iron oxide nanoparticle-based ethylcellulose nanocapsules for Cisplatin drug delivery.Co-encapsulation of dexamethasone 21-acetate and SPIONs into biodegradable polymeric microparticles designed for intra-articular delivery.Personalized Nanomedicine: A Revolution at the Nanoscale.Surface Modification of SPIONs in PHBV Microspheres for Biomedical Applications.Synthesis, surface modification and characterisation of biocompatible magnetic iron oxide nanoparticles for biomedical applicationsDesign, synthesis, characterisation and in vitro studies of hydrophilic, colloidally stable, 64Cu(ii)-labelled, ultra-small iron oxide nanoparticles in a range of human cell linesMagnetic targeting for site-specific drug delivery: applications and clinical potentialMaghemite/poly(d,l-lactide-co-glycolyde) composite nanoplatform for therapeutic applicationsInsulin-loaded PLGA microparticles: flow focusingversusdouble emulsion/solvent evaporation
P2860
Q27025163-D49B3335-163A-4925-85BE-DDCF5FECCEDCQ33684888-30E9CD17-8354-4ABA-99C9-70C4804ACAE5Q33693590-23B23195-6C5E-4AB7-9FDD-F06B42BAB1E3Q35040431-CE9FED30-EB9B-454B-9B57-52A3C34C8DE3Q37376480-4F1FBC99-969A-475A-BE41-F53D5BE2592AQ38135905-A02AA382-ABCA-452A-BBE0-0254FFB44F37Q38671640-70FA265C-D687-4B02-A0A2-4EA52D1DA62DQ38983089-861D54DE-79C4-4C69-A344-1CBD7C77B1A1Q41864542-4D4B7674-9C13-4568-B6A1-A154B09F5302Q41891459-24D88891-C603-46DE-9930-60354AC44A09Q43849342-7C0B5414-7F0E-4FB3-8DEA-53D027B998CBQ47159637-699C533F-82F4-43DE-A29F-364125C2528EQ54938154-F70C0709-92BC-4D8D-B9A5-BC77958E47CCQ57183728-CF61C591-E835-4DA5-865D-FE60F69485D8Q57376692-5D5D8A31-509F-4626-B0BC-89EA8E86ABDDQ57381726-862ECC2D-8802-4387-BA82-040EA0D28987Q58854679-135DDB68-079E-4412-BCF3-B9F82AB55A20Q58854686-A18AA47F-319F-485F-B500-23365FECDA6D
P2860
Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Optimization of iron oxide nan ...... ycolide) sub-micron particles.
@ast
Optimization of iron oxide nan ...... ycolide) sub-micron particles.
@en
type
label
Optimization of iron oxide nan ...... ycolide) sub-micron particles.
@ast
Optimization of iron oxide nan ...... ycolide) sub-micron particles.
@en
prefLabel
Optimization of iron oxide nan ...... ycolide) sub-micron particles.
@ast
Optimization of iron oxide nan ...... ycolide) sub-micron particles.
@en
P2093
P50
P1476
Optimization of iron oxide nan ...... lycolide) sub-micron particles
@en
P2093
Claude Linassier
Katel Hervé
Lazare Ngaboni Okassa
Pierre Dubois
Simone Cohen-Jonathan
P356
10.1016/J.EJPB.2006.12.020
P407
P577
2007-01-12T00:00:00Z